Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann Marie Navar

Showing results (1-10 of 259) with videos related to

Pageof 26
Sort By:
JAMA Cardiology|June 27, 2019
Fear-Based Medical Misinformation and Disease Prevention: From Vaccines to StatinsAnn Marie Navar
JAMA Cardiology|December 27, 2019
Questioning the Benefit of Statins for Low-Risk Populations-Medical Misinformation or Scientific Evidence?-ReplyAnn Marie Navar
JAMA|January 30, 2019
The Evolving Story of Triglycerides and Coronary Heart Disease RiskAnn Marie Navar
JAMA Cardiology|February 14, 2019
Statins Work, but Only in People Who Take ThemAnn Marie Navar
JAMA Cardiology|March 18, 2019
Electronic Health Record Data Quality Issues Are Not Remedied by Increasing Granularity of Diagnosis CodesAnn Marie Navar
Annals of Internal Medicine|April 16, 2019
Some patient interventions increased thiazide prescriptions and improved blood pressure controlAnn Marie Navar
JAMA Cardiology|December 8, 2022
Equity in Clinical Trial Participation Requires Equity in Identification and Treatment of Valvular Heart DiseaseAnn Marie Navar
Annals of Internal Medicine|July 21, 2015
ACP Journal Club. In adults without CV disease, most prediction scores overestimated risk for atherosclerotic CV eventsAnn Marie Navar, Michael Pencina
Radiology. Cardiothoracic Imaging|May 4, 2022
Limitations of Observational Studies for Aspirin in Primary Prevention and the Need for Randomized TrialsArzu Canan, Ann Marie Navar
JAMA Cardiology|April 23, 2020
High Rates of Off-label Prescribing and the Urgent Need for a Randomized Clinical TrialAnn Marie Navar, Roxana Mehran
Pageof 26

Showing results (1-10 of 259) with videos related to

Sort By:
Pageof 26
JAMA Cardiology|June 27, 2019
Fear-Based Medical Misinformation and Disease Prevention: From Vaccines to StatinsAnn Marie Navar
JAMA Cardiology|December 27, 2019
Questioning the Benefit of Statins for Low-Risk Populations-Medical Misinformation or Scientific Evidence?-ReplyAnn Marie Navar
JAMA|January 30, 2019
The Evolving Story of Triglycerides and Coronary Heart Disease RiskAnn Marie Navar
JAMA Cardiology|February 14, 2019
Statins Work, but Only in People Who Take ThemAnn Marie Navar
JAMA Cardiology|March 18, 2019
Electronic Health Record Data Quality Issues Are Not Remedied by Increasing Granularity of Diagnosis CodesAnn Marie Navar
Annals of Internal Medicine|April 16, 2019
Some patient interventions increased thiazide prescriptions and improved blood pressure controlAnn Marie Navar
JAMA Cardiology|December 8, 2022
Equity in Clinical Trial Participation Requires Equity in Identification and Treatment of Valvular Heart DiseaseAnn Marie Navar
Annals of Internal Medicine|July 21, 2015
ACP Journal Club. In adults without CV disease, most prediction scores overestimated risk for atherosclerotic CV eventsAnn Marie Navar, Michael Pencina
Radiology. Cardiothoracic Imaging|May 4, 2022
Limitations of Observational Studies for Aspirin in Primary Prevention and the Need for Randomized TrialsArzu Canan, Ann Marie Navar
JAMA Cardiology|April 23, 2020
High Rates of Off-label Prescribing and the Urgent Need for a Randomized Clinical TrialAnn Marie Navar, Roxana Mehran
Pageof 26